TGA-2023-0027-V227

Type II variation for application TGA-2023-0027. Type II variation: New Dosage Strength for Thymosilib — major revision

Variation Number
TGA-2023-0027-V227
Type
Type II
Application
TGA-2023-0027
Change
CHG-2022-0227
Status
Failed
Fee
€65,171
Submitted
2024-02-24
Approved
—
Description

Type II variation: New Dosage Strength for Thymosilib — major revision